Nccn Guidelines | List of Frontiers open access articles

Original Research

Published on 22 Feb 2022

Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lauren F. Huang
Augustine Hong
Gino Cioffi
Asrar Alahmadi
Tin-Yun Tang
Lee M. Ocuin
Nirav Patil
David L. Bajor
Joel N. Saltzman
Amr Mohamed

Frontiers in Oncology

doi 10.3389/fonc.2022.771688

5,346 views
6 citations

Original Research

Published on 24 Oct 2023

An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer

in Gastrointestinal Cancers: Colorectal Cancer

Zheng Hua Piao
Rong Ge
Lu Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1229998

3,656 views
10 citations

Case Report

Published on 05 Feb 2024

Case report: The utilization of crizotinib and brentuximab vedotin as a bridge to autologous stem cell transplantation and followed by CD30-directed CAR-T cell therapy in relapsed/refractory ALK+ ALCL

in Cancer Immunity and Immunotherapy

Wanying Liu
Jiaying Wu
Xi Ming
Qi Zhang
Delian Zhou
Rubing Zheng
Mi Zhou
Zhen Shang
Liting Chen
Xiaojian Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1346001

4,290 views
3 citations

Review

Published on 29 Jun 2022

Sentinel Lymph Node Mapping: Current Applications and Future Perspectives in Gynecology Malignant Tumors

in Nuclear Medicine

Tianyou Wang
Yan Xu
Wenyu Shao
Chao Wang

Frontiers in Medicine

doi 10.3389/fmed.2022.922585

17,387 views
17 citations

Original Research

Published on 11 Nov 2014

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines

in Radiation Oncology

Matthew Bernetich
Caspian Oliai
Rachelle Lanciano
Alexandra Hanlon
John Lamond
Stephen Arrigo
Jun Yang
Michael Good
Jing Feng
Royce Brown

Frontiers in Oncology

doi 10.3389/fonc.2014.00312

12,584 views
29 citations

Review

Published on 28 Jan 2026

Leveraging the transcriptome-phenotype relationship to guide clinical management of papillary thyroid cancer

in Thyroid Endocrinology

Adrian Harvey
Eric Walser
Rebecca Lahamm-Andraos
Caitlin Yeo
Samantha Wolfe
Cynthia Stretch
Steven Craig
Oliver F. Bathe

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1737469

599 views

Original Research

Published on 10 Jun 2021

Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment

in Women's Cancer

Zhaoyun Liu
Jing Shan
Qian Yu
Xinzhao Wang
Xiang Song
Fukai Wang
Chao Li
Zhiyong Yu
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.643654

3,921 views
16 citations

Mini Review

Published on 17 Jul 2023

Integrating biomarkers and multi-parametric MRI to provide enhanced clinical diagnosis for prostate cancer

in Urologic Oncology

Jason Alter
David M. Albala

Frontiers in Urology

doi 10.3389/fruro.2023.1235944

3,661 views
2 citations

Review

Published on 20 Jun 2025

HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities

in Thoracic Oncology

Ahmed Ismail
Aakash Desai
Yanis Boumber

Frontiers in Oncology

doi 10.3389/fonc.2025.1624124

13,784 views
7 citations

Review

Published on 01 Dec 2021

Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

in Breast Cancer

Lu Shen
Shizhen Zhang
Kaiyue Wang
Xiaochen Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.740227

9,148 views
17 citations

Systematic Review

Published on 11 Aug 2020

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

in Surgical Oncology

Francesco Giovinazzo
Fiammetta Soggiu
Jin-Young Jang
Eva Versteijne
Geertjan van Tienhoven
Casper H. van Eijck
Youngmin Han
Seong Ho Choi
Chang Moo Kang
Mark Zalupski

Frontiers in Oncology

doi 10.3389/fonc.2020.01112

5,805 views
14 citations

Original Research

Published on 09 Sep 2021

Reevaluation of Criteria and Establishment of Models for Total Thyroidectomy in Differentiated Thyroid Cancer

in Surgical Oncology

Zhenghao Wu
Yunxiao Xiao
Jie Ming
Yiquan Xiong
Shuntao Wang
Shengnan Ruan
Tao Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.691341

3,420 views
1 citation

Original Research

Published on 11 May 2021

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis

in Genitourinary Oncology

Matteo Ferro
Ottavio de Cobelli
Gennaro Musi
Giuseppe Lucarelli
Daniela Terracciano
Daniela Pacella
Tommaso Muto
Angelo Porreca
Gian Maria Busetto
Francesco Del Giudice

Frontiers in Oncology

doi 10.3389/fonc.2021.651745

9,437 views
17 citations

Original Research

Published on 12 Sep 2016

Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974–2011

in Radiation Oncology

Esther Yu
Paul P. Koffer
Thomas A. DiPetrillo
Timothy J. Kinsella

Frontiers in Oncology

doi 10.3389/fonc.2016.00203

8,347 views
40 citations

Case Report

Published on 03 Aug 2023

Hepatic cavernous hemangioma developed in non-small cell lung cancer patients after receiving Camrelizumab treatment: two case reports

in Radiation Oncology

Yonglong Jin
Jinpeng Xu
Dunmin Zhuang
Lina Dong
Yang Sun
Lin Zhao
Wenjing Xiao

Frontiers in Oncology

doi 10.3389/fonc.2023.1221309

3,469 views
3 citations

Case Report

Published on 14 Apr 2025

Unexpected outcomes of tislelizumab treatment in thoracic metastasis of malignant phyllodes tumors: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Yihao Liu
Zhixuan Duan
Minghui Liu
Yongwen Li
Min Wang
Jun Chen
Honglin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1535653

3,306 views

Articles

Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery

An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer

Case report: The utilization of crizotinib and brentuximab vedotin as a bridge to autologous stem cell transplantation and followed by CD30-directed CAR-T cell therapy in relapsed/refractory ALK+ ALCL

Sentinel Lymph Node Mapping: Current Applications and Future Perspectives in Gynecology Malignant Tumors

SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines

Leveraging the transcriptome-phenotype relationship to guide clinical management of papillary thyroid cancer

Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment

Integrating biomarkers and multi-parametric MRI to provide enhanced clinical diagnosis for prostate cancer

HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities

Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

Reevaluation of Criteria and Establishment of Models for Total Thyroidectomy in Differentiated Thyroid Cancer

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis

Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974–2011

Hepatic cavernous hemangioma developed in non-small cell lung cancer patients after receiving Camrelizumab treatment: two case reports

Unexpected outcomes of tislelizumab treatment in thoracic metastasis of malignant phyllodes tumors: a case report and literature review